CreatinerctRCTAnimal model2001

Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis.

Journal of applied physiology (Bethesda, Md. : 1985)

confidence

Key findings

CrM increased muscle total creatine and showed anticatabolic effects (reduced leucine oxidation, plasma leucine Ra) in men but not women; no increase in muscle protein synthesis or fat-free mass.

View source on PubMed (PMID 11509496) ↗

Sample size
27
Population
Young healthy men (n=13) and women (n=14)
Dosing
20 g/day for 5 days then 5 g/day for 3-4 days
Duration
8-9 days (20 g/day x 5 days, then 5 g/day x 3-4 days)
Route
oral
Blinding
not_reported
Controls
placebo
Drug class
nootropic

Measured endpoints

  • Muscle total creatineIncreasedmusculoskeletal
    significanteffect: +13.1%
  • Muscle phosphocreatineIncreasedmusculoskeletal
    trendeffect: +8.8%
  • Mixed-muscle protein fractional synthetic rateNo changemusculoskeletal
    not_significant
  • Leucine oxidation (men)Decreasedmetabolic
    significanteffect: -19.6%
  • Plasma leucine rate of appearance (men)Decreasedmetabolic
    significanteffect: -7.5%
  • Total body massNo changebody_composition
    not_significant
  • Fat-free massNo changebody_composition
    not_significant
Full abstract

Creatine monohydrate (CrM) supplementation during resistance exercise training results in a greater increase in strength and fat-free mass than placebo. Whether this is solely due to an increase in intracellular water or whether there may be alterations in protein turnover is not clear at this point. We examined the effects of CrM supplementation on indexes of protein metabolism in young healthy men (n = 13) and women (n = 14). Subjects were randomly allocated to CrM (20 g/day for 5 days followed by 5 g/day for 3-4 days) or placebo (glucose polymers) and tested before and after the supplementation period under rigorous dietary and exercise controls. Muscle phosphocreatine, creatine, and total creatine were measured before and after supplementation. A primed-continuous intravenous infusion of L-[1-(13)C]leucine and mass spectrometry were used to measure mixed-muscle protein fractional synthetic rate and indexes of whole body leucine metabolism (nonoxidative leucine disposal), leucine oxidation, and plasma leucine rate of appearance. CrM supplementation increased muscle total creatine (+13.1%, P < 0.05) with a trend toward an increase in phosphocreatine (+8.8%, P = 0.09). CrM supplementation did not increase muscle fractional synthetic rate but reduced leucine oxidation (-19.6%) and plasma leucine rate of appearance (-7.5%, P < 0.05) in men, but not in women. CrM did not increase total body mass or fat-free mass. We conclude that short-term CrM supplementation may have anticatabolic actions in some proteins (in men), but CrM does not increase whole body or mixed-muscle protein synthesis.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.